Targeting of RAG-dependent and -independent innate immune responses by the Ectromelia C15 protein
Ectromelia C15 蛋白靶向 RAG 依赖性和非依赖性先天免疫反应
基本信息
- 批准号:10364738
- 负责人:
- 金额:$ 22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-05 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAttenuatedB-LymphocytesBiological AssayCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell-Mediated CytolysisCellsCommunicable DiseasesCytolysisDNA VirusesDangerousnessDataDefense MechanismsDevelopmentDiseaseEctromeliaEffector CellEngineeringFamilyFamily memberFlow CytometryFutureGoalsHealthHomologous GeneHost DefenseHumanImmuneImmune EvasionImmune responseIn VitroInfectionInfectious EctromeliaInnate Immune ResponseKnock-outLeadLigandsLinkLiteratureLymphocyteMeasuresMediatingMemoryMolecular TargetMonkeypoxMouse Pox VirusMusNatural ImmunityNatural Killer CellsOrthopoxvirusOutcomePathogenesisPhasePlayPopulationPoxviridaePropertyProtein FamilyProteinsPublic HealthRecording of previous eventsRoleSmallpoxSmallpox VaccineT-Cell ActivationTechniquesTestingTherapeuticTherapeutic UsesVacciniaVesicular stomatitis Indiana virusViralViral ProteinsVirulenceVirulence FactorsVirulentVirusVirus ReplicationWorkadaptive immunitybasecell typeexperienceimmunological synapseimmunoregulationin vivoinsightmembermouse modelnovelpreventreceptorrecruitreplication factor Aresponse
项目摘要
PROJECT SUMMARY
Several members of the orthopoxvirus family, including variola (the cause of smallpox) and monkeypox, pose
serious threats to human health. Other members are equally severe in their natural hosts, including ectromelia
(ECTV), the cause of mousepox - a disease with many similarities to smallpox. The considerable virulence of
these large DNA viruses is attributable in great measure to their many proteins that impede both innate and
adaptive host defenses. The largest among these immunomodulatory proteins are the B22 family members,
which, despite their size and contributions to virulence, remain vastly understudied. Highly homologous B22
family members are present throughout the orthopoxviruses except for vaccinia, the attenuated orthopoxvirus
that has served as the smallpox vaccine for centuries. We focus in this exploratory R21 proposal on C15, the
B22 family member of ECTV. Deletion of C15 converts the virus from 100% lethal to 100% nonlethal in vivo
despite having no impact on replication in vitro. Our preliminary work with C15 has revealed two novel properties:
1) C15 potently and selectively inhibits CD4+ T cell activation in a way that inhibits assembly of the immunological
synapse. 2) In addition to targeting adaptive immunity, C15 also facilitates viral replication as early as 3 days
post infection, reflecting inhibition of innate immunity. Remarkably, C15 interferes with both RAG-dependent and
-independent components of innate immunity. Based on our preliminary data and the established literature, we
hypothesize that the RAG-independent component targeted by C15 is NK cell-mediated cytolysis and the RAG-
dependent component is bystander activation of memory CD8+ T cells (Trm). We further hypothesize that the
molecular target linking these two cell types is NKG2D, an activating receptor expressed by both NK cells and
Trm and shown previously to play an important role in defense against ECTV. Drawing from many years of
poxvirus experience and a wide range of established and cutting-edge techniques, we will test these three
hypotheses in three independent but complementary aims. Outcomes of this project could considerably enhance
understanding of orthopoxvirus pathogenesis and, more broadly, contribute to fundamental principles of
virus:host interplay. In addition, we anticipate that results will launch several subsequent projects including: a)
incorporation of CD4+ T cell inhibition in future mechanistic studies, b) examination of other B22 family members
and, c) the development of C15 derivatives for potential therapeutic modulation of host responses.
项目摘要
正托病毒家族的几个成员,包括Variola(天花的原因)和Monkeypox,姿势
对人类健康的严重威胁。其他成员的天然寄主同样严重,包括胚胎
(ECTV),是摩西司毒素的原因 - 一种与天花有许多相似之处的疾病。相当大的毒力
这些大型DNA病毒在很大程度上归因于它们的许多蛋白质,这些蛋白质既妨碍了先天和
自适应主机防御。这些免疫调节蛋白中最大的是B22家庭成员,
尽管它们的规模和对毒力的贡献,但仍被大量研究。高度同源的B22
家庭成员在整个正ox病毒中都存在,除了疫苗外,正tenodecoxvirus
几个世纪以来一直用作天花疫苗。我们专注于有关C15的探索性R21提案
ECTV的B22家庭成员。 C15的缺失将病毒从100%致死到100%非致死性体内
尽管对体外复制没有影响。我们与C15的初步工作揭示了两个新型的特性:
1)C15有效并选择性地抑制CD4+ T细胞激活,以抑制免疫学的组装
突触。 2)除靶向适应性免疫外,C15还早在3天就促进了病毒复制
感染后,反映了对先天免疫的抑制。值得注意的是,C15干扰了rag依赖性和
- 天生免疫的独立组成部分。根据我们的初步数据和既定文献,我们
假设由C15靶向的抹布独立成分是NK细胞介导的胞解和rag-
依赖性成分是记忆CD8+ T细胞(TRM)的旁观者激活。我们进一步假设
连接这两种细胞类型的分子靶标是NKG2D,这是NK细胞和NK细胞表达的激活受体
TRM并以前显示在防御ECTV中发挥重要作用。从多年
痘病毒的经验以及广泛的既定和尖端技术,我们将测试这三种
三个独立但互补的目标中的假设。该项目的结果可能会大大提高
对正托病毒发病机理的理解,更广泛地有助于
病毒:主机相互作用。此外,我们预计结果将启动几个随后的项目,包括:a)
在未来的机械研究中掺入CD4+ T细胞抑制作用,b)检查其他B22家族成员
c)C15衍生物的开发,用于宿主反应的潜在治疗调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurence Crane Eisenlohr其他文献
Laurence Crane Eisenlohr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurence Crane Eisenlohr', 18)}}的其他基金
Targeting of RAG-dependent and -independent innate immune responses by the Ectromelia C15 protein
Ectromelia C15 蛋白靶向 RAG 依赖性和非依赖性先天免疫反应
- 批准号:
10205831 - 财政年份:2021
- 资助金额:
$ 22万 - 项目类别:
Delineating the non-conventional MHC class I and class II peptidome of influenza
描述流感的非传统 MHC I 类和 II 类肽组
- 批准号:
10041955 - 财政年份:2020
- 资助金额:
$ 22万 - 项目类别:
Delineating the non-conventional MHC class I and class II peptidome of influenza
描述流感的非传统 MHC I 类和 II 类肽组
- 批准号:
10171775 - 财政年份:2020
- 资助金额:
$ 22万 - 项目类别:
Defining the MHC-II processing and presentation landscape of HIV-1
定义 HIV-1 的 MHC-II 处理和表达景观
- 批准号:
9762836 - 财政年份:2018
- 资助金额:
$ 22万 - 项目类别:
MHCII Cross-presentation as a Driver of CD4+ T Cell Responses to Poxviruses
MHCII 交叉呈递作为 CD4 T 细胞对痘病毒反应的驱动因素
- 批准号:
9198974 - 财政年份:2015
- 资助金额:
$ 22万 - 项目类别:
MHCII Cross-presentation as a Driver of CD4+ T Cell Responses to Poxviruses
MHCII 交叉呈递作为 CD4 T 细胞对痘病毒反应的驱动因素
- 批准号:
9108850 - 财政年份:2015
- 资助金额:
$ 22万 - 项目类别:
Alternative MHCII Processing of Influenza Virus Proteins
流感病毒蛋白的替代 MHCII 加工
- 批准号:
8764161 - 财政年份:2014
- 资助金额:
$ 22万 - 项目类别:
Class II Processing and Presentation During Secondary Responses to Influenza
流感二次反应期间的 II 类处理和呈现
- 批准号:
8823195 - 财政年份:2014
- 资助金额:
$ 22万 - 项目类别:
Alternative MHCII Processing of Influenza Virus Proteins
流感病毒蛋白的替代 MHCII 加工
- 批准号:
9280869 - 财政年份:2014
- 资助金额:
$ 22万 - 项目类别:
Alternative MHCII Processing of Influenza Virus Proteins
流感病毒蛋白的替代 MHCII 加工
- 批准号:
9061590 - 财政年份:2014
- 资助金额:
$ 22万 - 项目类别:
相似国自然基金
BLTA基因多态性位点rs1982809与严重创伤并发症易感性的临床关联和功能研究
- 批准号:81660317
- 批准年份:2016
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
B和T淋巴细胞衰减子(BTLA)在肾移植术后急性排斥反应中的作用及机制研究
- 批准号:81570676
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
BTLA联合CCR7基因共转染未成熟树突状细胞诱导皮肤移植免疫耐受的研究
- 批准号:81301634
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
BTLA修饰的未成熟树突状细胞对EAE免疫耐受作用及机制的研究
- 批准号:81271327
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
B、T淋巴细胞衰减因子对单纯疱疹性角膜基质炎复发的免疫调节作用
- 批准号:30772394
- 批准年份:2007
- 资助金额:29.0 万元
- 项目类别:面上项目
相似海外基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
- 批准号:
10821572 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Immunogenicity of the dengue vaccine CYD-TDV in a dengue virus serotype 1 immune population
登革热疫苗 CYD-TDV 在登革热病毒血清型 1 免疫群体中的免疫原性
- 批准号:
10728086 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Prevent IgM MGUS Progression by Targeting the Driver Mutation
通过针对驱动突变来预防 IgM MGUS 进展
- 批准号:
10745013 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Identification of serological markers of protection and risk for dengue vaccines and natural infection
鉴定登革热疫苗和自然感染的保护和风险的血清学标记
- 批准号:
10638037 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别: